久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Lifestyle
Home / Lifestyle / Health

Doctor brings AIDS vaccine project from US to Guizhou

By Liu Xiangrui in Beijing and Yang Jun in Guiyang | China Daily | Updated: 2017-04-21 08:09
Share
Share - WeChat

Zhou Xiangyang instructs a student in the Wistar Institute in Philadelphia, the United States. [Photo by Bian Ang/For China Daily]

For Zhou Xiangyang, AIDS research is full of challenges.

After graduating from Chongqing Medical University in 1982, he worked as a doctor in South China in the late 1980s and then went to study in France and the United States.

He joined the Wistar Institute, a Philadelphia-based biomedical research center, in 2007 and has served as its director of viral medicine since.

The 61-year-old has spent years researching HIV/AIDS and oncolytic vaccines, which have brought him international recognition.

According to the World Health Organization, there were about 36.7 million people living with HIV at the end of 2015, and about 46 percent of them were receiving antiretroviral treatment.

Zhou estimates that the number of people with HIV/AIDS in China has quadrupled in the past decade, mainly due to unsafe sex and drug abuse.

He remembers how a young Chinese couple he once treated shocked him and prompted him to strive harder to find a solution to the AIDS problem.

The couple had made their own wealth through hard work but were infected by HIV from taking drugs after they got rich, according to Zhou.

"As a doctor I felt the responsibility to reduce such patients' pain," he says.

He then gradually became involved in research on relevant vaccines.

His team embedded the enveloping protein of HIV into the carrier of chimpanzee adenovirus.

The method enhanced the immunogenicity of the protein.

Zhou says the AIDS prevention vaccine's development has had encouraging results during testing on animals and it has moved to the first phase of clinical trials in the US.

Lo Xiaoping from the QL Pharmaceutical Co Ltd, a company in Guizhou, invited Zhou to bring the vaccine research project to Southwest China's Guizhou province.

Earlier this year, the Chinese company signed a joint development plan with the Wistar Institute in the US.

Lo says Zhou has brought the "seeds" of the vaccine to his company, and the two sides will work together to carry it further.

Much work needs to be done in the near future, says Zhou.

For example, the virus strains from HIV carriers in Asia are different from those in the West, and lots of tests are needed to understand this.

While dealing with HIV/AIDS has been a challenge for doctors in any country, Zhou tells his students to maintain their patience.

As the doctor recalls, his experience of spending a few tough years in rural China when he was very young helped his persistence grow. The quality benefitted him in his research years later.

When he was studying for his PhD in France in the 1990s, he focused on molecular biological research. Back then, few people knew anything about the subject, Zhou says.

He needed to clone genes with methods that required using the enzyme endonuclease to cut the DNA sequence precisely.

But relevant research conditions in France were very poor then. It was hard to find and afford the expensive endonuclease.

He had to be very economical in using the enzyme. There were no other alternatives, either.

To reduce the use of incision enzyme, he had to improve the purity of DNA plasmid he collected from a bacteria and repeat the selection process several times.

As Zhou observes, the gap between China and Western countries in medical research has been narrowing. He believes Guizhou's strategies, including boosting the general health industry have been very positive factors for introducing talent.

"Guizhou has many beneficial factors for our project. It has a nice environment and huge government investment in terms of both capital and talent, which is attractive. We can enhance our competitiveness with more talent," Zhou says of the reason behind choosing Guizhou.

Lo says his company plans to soon recruit PhD-holders who will be sent for training at the Wistar Institute before they return to focus on AIDS-prevention research under Zhou's guidance.

Li Jiaxu contributed to this story.

Related:

Sichuan cross-country runs set for May Day weekend

Family doctors help 'better manage' health

Most Popular
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 黄影| 国产三级黄色片 | 日本特黄特色大片免费视频网站 | 殴美毛片 | 日本黄页网站在线观看 | 一级待一黄aaa大片在线还看 | 欧美午夜性春猛交 | 欧美另类亚洲一区二区 | 国产主播福利片在线观看 | 最新国产中文字幕 | 九九九国产视频 | 成人夜色视频网站在线观看 | 免看一级一片一在线看 | 怡红院在线a男人的天堂 | 精品免费久久久久欧美亚一区 | 99视频有精品视频免费观看 | 欧美一级高清视频在线播放 | 中文成人在线 | 亚洲综合精品一二三区在线 | 日本aaa成人毛片 | 亚洲视频免费在线看 | 岛国在线免费观看 | 国产麻豆入在线观看 | 久草a视频| 91在线免费观看网站 | 久久久精品成人免费看 | 国产亚洲午夜精品a一区二区 | 91视频国产91久久久 | 免费毛片a线观看 | 久久久精品免费热线观看 | 中文在线观看视频 | 成人做爰视频www | 99久久国产综合精品五月天 | 欧美一级特黄真人毛片 | 日韩欧美高清在线 | 国产成人午夜极速观看 | 成人欧美一区在线视频在线观看 | 在线免费看a | 日本一本色道 | 黄色影院在线 | 99在线观看巨臀大臀视频 |